Core Insights - Codis has announced a significant expansion of its manufacturing capabilities in the UK by investing in a GEA Pharma-SD® type PSD-4 solvent-capable spray dryer, making it the only UK CDMO to offer this capacity [1][1][1] Group 1: Investment and Capacity Expansion - The new PSD4 spray dryer will be operational in 2027 and will enhance Codis' existing amorphous solid dispersion platform, allowing for increased production capacity [1][1] - The PSD4 is designed to produce commercial batches up to 500 kg, with a total capacity of 30,000 kg per year, addressing the growing demand for solvent-based spray drying of amorphous solid dispersions [1][1][1] Group 2: Government Support and Economic Impact - The investment is supported by the UK government's Life Sciences Innovative Manufacturing Fund (LSIMF), which offers up to £520 million in capital grants to life science manufacturers [1][1] - The construction and installation of the PSD4 will create short-term employment opportunities in the Haverhill region, with additional long-term roles expected as production increases [1][1][1] Group 3: Strategic Importance - This expansion is seen as a milestone in Codis' evolution as a global leader in spray drying and amorphous solid dispersions, enabling customers to bring more bioavailability-enhanced medicines to market [1][1] - The project will rely on local suppliers and contractors, contributing to sustained economic development within the region's life sciences ecosystem [1][1]